Kintor Pharmaceutical Limited



简体

繁体

搜索

ABOUT US

关于开拓



The Company’s founder and CEO, Dr. Youzhi Tong was a vice-president of Angion Biomedica Corp., a company in the United States. He has more than 25 years of experience in new drug R&D and management. Inspired by the leadership of Dr. Tong, a group of excellent scientists and industry experts are working collaboratively to achieve company’s vision.

Youzhi Tong

Founder
Chairman of the Board/CEO

Over 25 years of experience in biopharm R&D and management
VP of Angion Biomedica in the U.S.
Assistant professor of Albert Einstein College of Medicine
Ph.D. in pharmacology from Cornell; MA and BA in Chemistry from PKU

Xunwei Dong

CMO

Over 18 years medical related experience in Novartis, Pfizer and GSK
Previous Clinical Development Medical director of Novartis
10 years experience as an attending surgeon
M.D. from Peking Union Medical College

Qun Lu

CTO

20+ years of experience in CMC development in Pfizer, Merck and Celgene Corp./BMS
Member of the board of directors of International Consortium for Innovation and Quality in Pharmaceutical Development
Ph.D. in Physical Chemistry at Arizona State University; BA in Chemistry from PKU

Lucy Lu

CFO

Over 13 years of experience in investment banking business
Former Director and Managing Director of GF Capital (Hong Kong)
Former executive director of UBS Hong Kong in Asia healthcare group
MA in Finance from Peking University; BA in Finance from Renmin University of China

Liandong Ma

VP/ Head of Institute of R&D

20 years of experience in oncology drug development
Former Senior Research Scientist at Eli Lily
Led and participated in more than 10 tumor drug development projects, and advanced 4 drugs to clinical stage
MA and BA in medicine from Harbin Medical University

Ruo Xu

VP/Chemistry

Over 20 years experience in pharmaceutical company
Former principal scientist, Schering-Plough/Merck
Former general manager, API Inc. in New Jersey
Ph. D. Columbia University; BS Peking University

Jianfei Yang

VP/Biologics

Over 18 years of experience in immune-related drug development
Former Principal Scientist at GSK, USA
Former Senior Scientist at Boehringer Ingelheim, USA
Ph.D. in Pathology/Immunology, Niigata University, Japan

Jiawen Han

VP/BD

25+ years of experience in drug development and business operations
Former VP of QiluBoston and Wuxi AppTecPharmaceutical Inc
M.D. from Peking University, Ph.D.from University of Rochester School of Medicine

Juping Shen

Deputy General Manager

Over 30 years experience in pharmaceutical manufacturing and quality management
Former Deputy General Manager of Nanjing Sanhome Pharmaceutical
Former Quality Director of CTTQ Pharma group
Major drafter of China's GMP

Jie Chen

Deputy General Manager

Rich experience in the field of total synthesis of natural products and the design and development of drug molecules
Adjunct visiting researcher at Suzhou Research Institute, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences
Ph.D., Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Postdoctoral, University of Texas Southwestern Medical Center

Luke Cheung

VP/Investment&International Commerce

15+ experience in financial and investment industry
Former head of Leveraged & Acquisition Finance in Haitong International
Master of Philosophy, Medical School, the University of Hong Kong
BSc in Biochemistry, the Hong Kong University of Science and Technology